Provided are a humanized monoclonal antibody or antibody fragment thereof for selectively inhibiting vascular endothelial lipase activity, effective for treating arteriosclerosis or metabolic syndrome, and a medical composition including the humanized monoclonal antibody or antibody fragment thereof as an active ingredient.